Charles River Laboratories Intl. Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Charles River Laboratories Intl. Inc trades at $301.4 (market cap $14.23B), while Direxion Daily Semiconductor Bear 3X Shares trades at $34.37 (market cap $1.96B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 7.3× Direxion Daily Semiconductor Bear 3X Shares's market cap, and Charles River Laboratories Intl. Inc is trading nearer its 52-week high, Direxion Daily Semiconductor Bear 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and Direxion Daily Semiconductor Bear 3X Shares for 11 Days on average.
| CRL | SOXS | |
|---|---|---|
Market Cap | $14.23B | $1.96B |
Volume | 1,176,885 | 113,512,541 |
Sector | Health | Leveraged / Inverse |
52-Week High | $310.77 | $988.00 |
52-Week Low | $149.93 | $29.62 |
Typical Hold Time | 33 Days | 11 Days |
Enterprise Value | $17.06B | — |
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $301.79, up 0.5% with strong analyst support (73% buy ratings) and a $305.50 consensus target. The stock shows bullish technical momentum above key support levels, though fundamentals reveal challenges with negative net income margins (-5.96%) and elevated P/E ratio (684.85). Recent quarterly earnings beats and a new 2030 growth strategy provide optimism, but profitability concerns persist amid flat revenue trends.
The outlook balances near-term technical strength against fundamental headwinds. Investment opportunity lies in execution of the 5-7% growth target and $300M savings plan, while risks include sustained negative profitability, high debt levels ($2.24B), and margin pressure. Current price near resistance at $304 suggests limited upside without fundamental improvement.
SOXS, the Direxion Daily Semiconductor Bear 3X ETF, is trading at $34.39, up 12.22% today, reflecting its inverse leveraged exposure to semiconductor stocks. The technical picture is bearish overall, with moving averages signaling a downtrend. Recent news highlights the fund's volatility and tactical use during semiconductor sector pullbacks, driven by factors like AI demand fluctuations and competitive pressures on chipmakers.
The outlook for SOXS remains highly speculative, suitable only for short-term traders betting against semiconductors. Key risks include the fund's decay from daily rebalancing, reliance on semiconductor volatility, and potential for rapid losses if the sector rallies. Investors should avoid long-term holdings due to structural erosion and elevated volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →